Dutta, P.Wadhawan, G.2024-09-242024-09-242023-02Dutta P., Wadhawan G.. Lymph node metastasis after neoadjuvant chemotherapy. International Journal of Medical Research & Review . 2023 Jan; 11(1): 18- 212320-86862321-127Xhttps://imsear.searo.who.int/handle/123456789/231059Neoadjuvant therapy refers to the systemic treatment of breast cancer prior to definitive surgical from size reduction before conservation therapy. Response to neoadjuvant chemotherapy is evaluated by the change in tumor size from pretreatment clinical and or radiologic measurement to post-treatment status. The spectrum of response to neoadjuvant chemotherapy varies from complete response, partial response, to non-response. This concept is the same in breast tumors as well as axillary lymph nodes. The presented case is a known case of Triple Negative Invasive Ductal carcinoma with Axillary involvement Right Breast since November 2020 and had undergone NeoadjuvantChemotherapy till February 2021,followed by surgical intervention in October 2022.Triple Negative Breast carcinomaAxillary Lymph node metastasisNeoadjuvant ChemotherapyDefaulter.Journal ArticleIndiaPooja Dutta,Post Graduate Resident, Department of General Surgery, Pacific Medical College and Hospital, Bhilon ka Bedla, Udaipur Rajasthan, IndiaGaurav Wadhawan, Professor,Department of General Surgery Pacific Medical College and Hospital,Bhilon, ka Bedla, Udaipur, Rajasthan, India